| Name
|
[Lys8] Vasopressin
|
| Code
|
[50-57-7]
|
| The alias
|
[Lys8] Vasopressin
|
| Sequence (single letter abbreviation)
|
CYFQNCPKG-NH2?(Cys1&Cys6 bridge)
|
| Sequence (three-letter abbreviation)
|
H-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2?(trifluoroacetate salt)(Cys1 and Cys6 bridge)
|
| A basic description
|
A 28 amino acid peptide synthesized in the central nervous system and gastrointestinal tract. It belongs to the secretin glucagon-CRF family and is widely distributed in the central and peripheral nervous systems. In acting as both a neurotransmitter and hormone that has powerful hypotensive and vasodilatory effects, this peptide plays a wide role in a range of biological activities, including vaso- and bronchodilation, smooth muscle relaxation, and stimulation of secretin. When paired with the adrenegic drug phentolamine and injected, this peptide is expected to provide a new and effective solution for patients suffering from erectile dysfunction.
|
| solubility
|
|
| The molecular weight
|
1056.3
|
| Chemical formula
|
C46H65N13O12S2
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
(Cys1 and Cys6 bridge)
|